According to FutureWise analysis the market for peripheral artery disease is expected to reach US$ 9.07 billion by 2031 at a CAGR of 9.2%.
FutureWise Market Research has instantiated a report that provides an intricate analysis of Peripheral Artery Disease Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the Peripheral Artery Disease Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.
Peripheral artery disease (PAD) is a common circulatory problem in which narrowed arteries reduce blood flow to limbs. PAD usually affects arteries in the legs and sometimes affects the arteries that carry blood from the heart to the head, arms, kidneys, and stomach. It is caused by the deposition of fats (plaques) in the artery walls, which reduces the blood flow to organs, limbs, and the head.
According to Surveys, about 6.5 million people aged 40 and older in the U.S. have PAD. Both women and men are affected by PAD; but, African Americans have an increased risk of PAD. The ageing population, which leads to an increase in the prevalence of peripheral artery disease , as well as an increase in product approvals, are all variables that raise the risk of developing peripheral arterial disease (PAD).